Two other polymorphisms (XPD Lys751Gln and ERCC6 Gly399Asp) showed similar trends, but the differences between T ≥ 2 low grade tumors and T ≥ 2 high grade carcinomas were not statistically confirmed (Figure 3(b)). The gene discussed is ERCC2; the disease is carcinoma.